Sanofi (NASDAQ:SNY) Shares Gap Down to $50.11

Sanofi (NASDAQ:SNY)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $50.11, but opened at $48.22. Sanofi shares last traded at $48.61, with a volume of 1,008,582 shares.

Sanofi Price Performance

The stock has a 50 day moving average price of $48.59 and a 200-day moving average price of $48.54. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.27 and a quick ratio of 0.87. The stock has a market capitalization of $121.77 billion, a price-to-earnings ratio of 24.16, a price-to-earnings-growth ratio of 1.50 and a beta of 0.60.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings data on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.96. The company had revenue of $11.36 billion during the quarter, compared to analysts’ expectations of $11.75 billion. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. On average, analysts forecast that Sanofi will post 4.13 earnings per share for the current year.

Institutional Investors Weigh In On Sanofi

Hedge funds have recently modified their holdings of the company. Cascade Investment Advisors Inc. grew its stake in shares of Sanofi by 4.7% in the 1st quarter. Cascade Investment Advisors Inc. now owns 34,359 shares of the company’s stock valued at $1,670,000 after buying an additional 1,535 shares during the period. Dynamic Advisor Solutions LLC acquired a new stake in Sanofi during the fourth quarter worth $2,104,000. Vestal Point Capital LP purchased a new stake in Sanofi in the fourth quarter valued at $14,919,000. Oxbow Advisors LLC acquired a new position in shares of Sanofi in the 4th quarter valued at $4,689,000. Finally, China Universal Asset Management Co. Ltd. grew its holdings in shares of Sanofi by 348.1% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 32,456 shares of the company’s stock worth $1,614,000 after purchasing an additional 25,213 shares during the period. Hedge funds and other institutional investors own 10.04% of the company’s stock.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.